Seelos Therapeutics to Present a Poster on SLS - 002 ( Intranasal Racemic Ketamine ) at the 2021 IASR / AFSP International Summit on Suicide Research

Scientists have been selected to present a poster on an open label study of the effectiveness of ketamine in adults with Major Depressive Disorder at Imminent Risk of Suicide (MDD) at the start of this year's suicide conference in New York.

Source: prnewswire.com
Published on 2021-10-01